TrialCancer prevention research (Philadelphia, Pa.)2020

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index.

Jason A Zell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.